Immunotherapy for recurrent miscarriage.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2014-10-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD000112.pub3PMID 25331518PMCID PMC7051032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration

  2013cited by this paper
• A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.

  2013cited by this paper
• Effect of intravenous immunoglobulin on pregnancy outcome following IVF/ICSI in infertile patients with endometriosis

  2012cited by this paper
• SELECTED ORAL COMMUNICATION SESSION, SESSION 34: EARLY PREGNANCY LOSS PROGNOSIS AND TREATMENT, Tuesday 5 July 2011 10:00 – 11:30

  2011cited by this paper
• Granulocyte colony-stimulating factor for the treatment of recurrent miscarriage

  2011cited by this paper
• Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.

  2010cited by this paper
• [Effectiveness of intravenous immunoglobulin therapy in treating unexplained recurrent spontaneous abortion and its effect on the level of serum soluble human leucocyte antigen G].

  2010cited by this paper
• Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium

  2009cited by this paper
• Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial.

  2009cited by this paper
• Immunotherapy for recurrent miscarriage.

  2006cited by this paper
• Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.

  2004cited by this paper
• Regulatory T cells mediate maternal tolerance to the fetus

  2004cited by this paper
• A noninflammatory pathway for pregnancy loss: innate immune activation?

  2004cited by this paper
• Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion

  2004cited by this paper
• Effect of IgG Therapy on Lymphocyte Subpopulations in the Peripheral Blood of Kuwaiti Women Experiencing Recurrent Pregnancy Loss

  2004cited by this paper
• Pre‐conceptional Natural Killer Cell Activity and Percentage as Predictors of Biochemical Pregnancy and Spontaneous Abortion with Normal Chromosome Karyotype

  2003cited by this paper
• Immunotherapy for recurrent miscarriage.

  2003cited by this paper
• A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage.

  2002cited by this paper
• Recurrent miscarriage: a defect in nature's quality control?

  2002cited by this paper
• Prevention of T cell–driven complement activation and inflammation by tryptophan catabolism during pregnancy

  2001cited by this paper
• Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage.

  2001cited by this paper
• NK Cell Activity and Subsets in Women with a History of Spontaneous Abortion

  2001cited by this paper
• Placental development: Lessons from mouse mutants

  2001cited by this paper
• Massive Intravenous Immunoglobulin Treatment in Women with Four or More Recurrent Spontaneous Abortions of Unexplained Etiology: Down‐Regulation of NK Cell Activity and Subsets

  2001cited by this paper
• A critical role for murine complement regulator crry in fetomaternal tolerance.

  2000cited by this paper
• Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial.

  1999cited by this paper
• Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study.

  1999cited by this paper
• Mini symposium: analysis of therapies for anovulation and miscarriage. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage

  1999cited by this paper
• Prevention of Unexplained Recurrent Spontaneous Abortion Using Intravenous Immunoglobulin: A Prospective, Randomized, Double‐Blinded, Placebo‐Controlled Trial

  1998cited by this paper
• Recurrent miscarriage (REMIS) study: how should data from women who do not become pregnant be handled?

  1998cited by this paper
• [Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal-fetal immuno-recognition].

  1998cited by this paper
• Intravenous Immunoglobulin Therapy for Recurrent Spontaneous Abortion: A Meta‐Analysis

  1998cited by this paper
• Microsatellite mutations in spontaneously aborted embryos.

  1998cited by this paper
• Transmission disequilibrium of maternally-inherited CTLA-4 microsatellite alleles in idiopathic recurrent miscarriage.

  1998cited by this paper
• Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28.

  1997cited by this paper
• Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian study.

  1997cited by this paper
• Elevated Peripheral Blood Natural Killer Cells Are Effectively Downregulated by Immunoglobulin G Infusion in Women With Recurrent Spontaneous Abortions

  1996cited by this paper
• Effect of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion.

  1996cited by this paper
• Fertility Among Women With Recurrent Spontaneous Abortions—The Effect of Paternal Cell Immunization Treatment

  1995cited by this paper
• A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters.

  1995cited by this paper
• Death before birth: clues from gene knockouts and mutations.

  1995cited by this paper
• Intravenous Immunoglobulin for Treatment of Recurrent Pregnancy Loss

  1995cited by this paper
• Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin.

  1995cited by this paper
• Preconceptional natural-killer-cell activity as a predictor of miscarriage.

  1995cited by this paper
• Fertility among women with recurrent spontaneous abortions--the effect of paternal cell immunization treatment.

  1995cited by this paper
• Reports of Independent Analyses of Data From the Worldwide Prospective Collaborative Study on Immunotherapy for Unexplained Recurrent Spontaneous Abortion

  1994cited by this paper
• Abstracts of Contributors' Individual Data Submitted to the Worldwide Prospective Observation Study on Immunotherapy for Treatment of Recurrent Spontaneous Abortion

  1994cited by this paper
• Potential Alloimmune Factors and Immunotherapy in Recurrent Miscarriage

  1994cited by this paper
• Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.

  1994cited by this paper
• Alternative Treatment to Lymphocyte Immunization for Treatment of Recurrent Spontaneous Abortion: Immunotherapy With Intravenous Immunoglobulin for Treatment of Recurrent Pregnancy Loss: American Experience

  1994cited by this paper
• Placebo‐controlled trial of active immunization with third party leukocytes in recurrent miscarriage

  1994cited by this paper
• Side-effects of intravenous immune globulins.

  1994cited by this paper
• Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin versus placebo.

  1994cited by this paper
• Intravenous immunoglobulin in the prevention of recurrent miscarriage

  1994cited by this paper
• Worldwide Collaborative Observational Study and Meta‐Analysis on Allogenic Leukocyte Immunotherapy for Recurrent Spontaneous Abortion 1

  1994cited by this paper
• Immunotherapy and recurrent abortion: a randomized clinical trial.

  1994cited by this paper
• Immunization as therapy for recurrent spontaneous abortion: A review and meta‐analysis

  1993cited by this paper
• Clinical evaluation of immunotherapy in early pregnancy with x-irradiated paternal mononuclear cells for primary recurrent aborters.

  1993cited by this paper
• Treatment of Recurrent Spontaneous Abortion by Immunization With Paternal Lymphocytes: Results of a Controlled Trial

  1993cited by this paper
• [Immunological treatment of spontaneous repeated abortions. The value of transfusing the partner's leukocytes in the third week of gestation].

  1993cited by this paper
• Humoral immune response to lymphocyte antigens in early pregnancy and after leucocyte immunotherapy

  1993cited by this paper
• Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions

  1992cited by this paper
• Immunologic tests in the evaluation of reproductive disorders: a critical review.

  1992cited by this paper
• Trials and Tribulation in the Treatment of Recurrent Spontaneous Abortion

  1991cited by this paper
• Treatment of Recurrent Aborters by Immunization With Paternal Cells—Controlled Trial

  1991cited by this paper
• Epidemiology of Recurrent Spontaneous Abortion

  1991cited by this paper
• Immunotherapy for Recurrent Spontaneous Abortions in a Chinese Population

  1991cited by this paper
• Immunological Mechanisms of Pregnancy Maintenance and Failure: A Critique of Theories and Therapy

  1990cited by this paper
• Immunological studies in recurrent spontaneous abortion: effects of immunization of women with paternal mononuclear cells on lymphocytotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA and pregnancy outcome.

  1988cited by this paper
• Immunologic aspects of recurrent abortion and fetal death.

  1987cited by this paper
• Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells.

  1985cited by this paper
• Letter: Radioimmunoassay of apo-L.D.L.

  1974cited by this paper

• Effect of prednisolone on live birth rate in women with unexplained recurrent pregnancy loss: a study protocol for a double-blind, placebo-controlled, multicentre, randomised controlled trial (PREMI-study)

  2025cites this paper
• Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure

  2025cites this paper
• Infertility Evaluation and Treatment.

  2025cites this paper
• Interventions to Improve Outcomes After Pregnancy Loss: A Systematic Review

  2025cites this paper
• Efficacy of Granulocyte Colony Stimulating Factor in Reducing First Trimester Miscarriages in Women With a History of Recurrent Pregnancy Loss: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Intravenous immunoglobulin versus placebo in recurrent pregnancy loss: A systematic review and meta-analysis of randomized trials.

  2025cites this paper
• Expression of NKp46 and other activating inhibitory receptors on uterine endometrial NK cells in females with various reproductive failures: A review

  2025cites this paper
• Immune Treatment Strategies in Unexplained Recurrent Pregnancy Loss

  2025cites this paper
• 2025 American Society for Reproductive Immunology Guidelines for the Treatment of Recurrent Pregnancy Losses: Practice Recommendations From the ASRI Clinical Reproductive Immunology Fellowship

  2025cites this paper
• Efficacy of intravenous immunoglobulin in recurrent pregnancy loss: a retrospective analysis of patients with abnormal cellular immunity

  2025cites this paper
• Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: a protocol for a multicenter, randomized, double-blind, controlled trial

  2025cites this paper
• Burden, causes, and treatment approaches of recurrent pregnancy loss: a scoping review

  2025cites this paper
• Infertility Evaluation and Treatment.

  2025cites this paper
• PBX1 attenuates inflammation and apoptosis of trophoblast cells induced by LPS through downregulating the transcription of TMUB1: PBX1 ameliorates RSA development

  2025cites this paper
• Research overview and hotspots in the field of recurrent miscarriage: A literature-mining study

  2025cites this paper
• Recurrent Pregnancy Loss

  2025cites this paper
• Chromosomal abnormalities in primary and secondary recurrent miscarriages: significance for PGT-A

  2025cites this paper
• Efficacy of therapeutic interventions for idiopathic recurrent pregnancy loss: a systematic review and network meta-analysis

  2025cites this paper
• Single Nucleotide Polymorphism of IL-18 (Rs 1946519) in Recurrent Aborted Iraqi Women and Its Association with Toxoplasmosis

  2024cites this paper
• Overexpression of regulatory T cells in patients with unexplained recurrent pregnancy loss: friend or foe?

  2024cites this paper
• Immunology Updates in Recurrent Implantation Failure in In Vitro Fertilization

  2024cites this paper
• Australasian recurrent pregnancy loss clinical management guideline 2024, part II

  2024cites this paper
• The investigation and management of recurrent early pregnancy loss: a Canadian Fertility and Andrology Society clinical practice guideline.

  2024cites this paper
• Maternal‐fetal immunity and recurrent spontaneous abortion

  2024cites this paper
• Bibliometric analysis of the global trends in immune‐related recurrent pregnancy loss research over the last two decades

  2024cites this paper
• Maternal–Fetal Compatibility in Recurrent Pregnancy Loss

  2024influential citation
• Hsa-Mir-1 and Hsa-Mir-1229 expression levels in recurrent miscarriage patients before and after lymphocyte therapy in comparison to control groups

  2024cites this paper
• The use of immunotherapies for recurrent miscarriage: An overview of systematic reviews and meta-analysis.

  2023cites this paper
• Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3+CD8+CD56+ Natural Killer T Population in Women with Recurrent Spontaneous Abortion

  2023cites this paper
• The Diagnostics and Treatment of Recurrent Pregnancy Loss

  2023cites this paper
• High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.

  2023cites this paper
• Immune globulin

  2023cites this paper
• Recurrent MiscarriageGreen‐top Guideline No. 17

  2023cites this paper
• Recurrent pregnancy loss and inherited thrombophilias: Does low molecular weight heparin improve the live birth rate?

  2023cites this paper
• Pregnancy by Oocyte Donation: Reviewing Fetal–Maternal Risks and Complications

  2023cites this paper
• Investigation and Management of Recurrent Pregnancy Loss: A Comprehensive Review of Guidelines

  2023cites this paper
• Intravenous immunoglobulin for recurrent pregnancy losses? Possible mechanism and current evidence

  2023cites this paper
• Peripheral blood natural killer cell cytotoxicity in recurrent miscarriage: a systematic review and meta-analysis.

  2023cites this paper
• The Influence of Maternal KIR Haplotype on the Reproductive Outcomes after Single Embryo Transfer in IVF Cycles in Patients with Recurrent Pregnancy Loss and Implantation Failure—A Single Center Experience

  2023cites this paper
• ESHRE guideline update 2022: New perspectives in the management of couples with recurrent pregnancy loss

  2023cites this paper
• Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial

  2023cites this paper
• Effect of a 20% intravenous fat emulsion therapy on pregnancy outcomes in women with RPL or RIF undergoing IVF/ICSI: a systematic review and meta-analysis

  2023influential citation
• Successful Pregnancy and Delivery at Term Following Intravenous Immunoglobulin Therapy with Heparin for Unexplained Recurrent Pregnancy Loss Suspected of Immunological Abnormalities: A Case Report and Brief Literature Review

  2023cites this paper
• Omega‐3 fatty acid supplements and recurrent miscarriage: A perspective on potential mechanisms and clinical evidence

  2023cites this paper
• Efficacy of lymphocyte immunotherapy in the treatment of recurrent pregnancy loss from alloimmunity: A systematic review and meta‐analysis

  2022cites this paper
• Efficacy of intravenous immunoglobulin in the treatment of recurrent spontaneous abortion: A systematic review and meta‐analysis

  2022cites this paper
• [HLA-C KIR interactions and placental defects: implications in ART pregnancy issues].

  2022cites this paper
• Contribution of immunology to build precision medicine in reproduction: present and future

  2022cites this paper
• Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

  2022cites this paper
• Adverse drug reactions following lymphocyte immunotherapy for the treatment of infertility: A retrospective study

  2022cites this paper
• Reproductive immune microenvironment.

  2022cites this paper
• Next generation of immune checkpoint molecules in maternal‐fetal immunity *

  2022cites this paper
• Unexplained recurrent pregnancy loss: Novel causes and advanced treatment.

  2022cites this paper
• Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples

  2022cites this paper
• Recurrent Pregnancy Loss

  2022cites this paper
• Immunotherapies to optimize pregnancy outcomes in subfertile women.

  2022cites this paper
• Decidual macrophages in recurrent spontaneous abortion

  2022cites this paper
• Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/050, May 2022)

  2022cites this paper
• Recent Advances in Treatment of Recurrent Spontaneous Abortion

  2022cites this paper
• Role of lymphocyte immunization therapy (LIT) in repeated miscarriages – A review

  2022cites this paper
• Moving innovation to practice: an Ethics Committee opinion.

  2021cites this paper
• Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten

  2021cites this paper
• Recurrent miscarriage: evidence to accelerate action.

  2021cites this paper
• Uterine natural killer cells and recurrent spontaneous abortion

  2021cites this paper
• Evaluation of paternal lymphocyte immunotherapy and potential biomarker mixed lymphocyte reaction‐blocking factor in an Argentinian cohort of women with unexplained recurrent spontaneous abortion and unexplained infertility

  2021cites this paper
• Genetic testing of products of conception in recurrent pregnancy loss evaluation.

  2021cites this paper
• Effects of Cytokines Supplementation in human Embryo Culture Medium in patients with previous recurrent pregnancy loss.

  2021cites this paper
• Lipid emulsion therapy in women with recurrent pregnancy loss and repeated implantation failure: The role of abnormal natural killer cell activity

  2021cites this paper
• Recurrent implantation failure – an overview of current research

  2021cites this paper
• Lymphocyte immunotherapy in recurrent miscarriage and recurrent implantation failure

  2021cites this paper
• Understanding human immunity in idiopathic recurrent pregnancy loss.

  2021cites this paper
• Uterine natural killer cells: from foe to friend in reproduction.

  2021cites this paper
• Efficacy of dydrogesterone on treating recurrent miscarriage and its influence on immune factors: a systematic review and meta-analysis.

  2021cites this paper
• Immunotherapy for recurrent pregnancy loss: a reappraisal

  2021cites this paper
• THE ROLE OF IMMUNE INTERACTION BETWEEN NATURAL KILLER CELLS AND HLA-C MOLECULES IN RECURRENT SPONTANEOUS ABORTION IN WOMEN OF BASRAH PROVINCE

  2021cites this paper
• Decidual CXCR4+CD56brightNK cells as a novel NK subset in maternal–foetal immune tolerance to alleviate early pregnancy failure

  2021cites this paper
• The Role of Uterine Natural Killer Cells on Recurrent Miscarriage and Recurrent Implantation Failure: From Pathophysiology to Treatment

  2021cites this paper
• Live Birth Rates after Active Immunization with Partner Lymphocytes

  2021cites this paper
• Role of Endometrial Scratch in UnExplained infertility (RESCUE); A Randomized Clinical Trial

  2021cites this paper
• Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion

  2021cites this paper
• Association between vaginal microbiota and risk of early pregnancy miscarriage.

  2021cites this paper
• Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art

  2021cites this paper
• A systemic review of intravenous immunoglobulin G treatment in women with recurrent implantation failures and recurrent pregnancy losses

  2021cites this paper
• Effects of intralipid infusions on anti‐trophoblast antibody (ATAb)‐activities in patients with recurrent pregnancy loss: An observational report

  2021cites this paper
• Immunotherapies and Unexplained Infertility

  2020cites this paper
• Recurrent Pregnancy Loss

  2020cites this paper
• NLRP3 inflammasome: a new therapeutic target for high-risk reproductive disorders?

  2020cites this paper
• Reply to letter to the editor: “Safety of lymphocytes immunotherapy during the COVID-19 outbreak in Wuhan, China”

  2020cites this paper
• Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand

  2020cites this paper
• Changes in Gut Microorganism in Patients with Positive Immune Antibody-Associated Recurrent Abortion

  2020cites this paper
• Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.

  2020cites this paper
• Antenatal management of singleton pregnancies conceived using assisted reproductive technology

  2020cites this paper
• The role of immunotherapy in prevention of preeclampsia and influence on the condition of pregnant women and newborns

  2020cites this paper
• Immunoglobulin Therapy

  2020cites this paper
• The place of immunological factors in recurrent pregnancy loss and implantation failures

  2020cites this paper
• The optimal timing of immunotherapy may improve pregnancy outcome in women with unexplained recurrent pregnancy loss: A perspective follow‐up study in northeastern China

  2020cites this paper
• A narrative review of adjuvants in in vitro fertilisation: evidence for good clinical practice

  2020cites this paper
• COVID-19 and immunomodulation treatment for women with reproductive failures

  2020cites this paper
• Lymphocyte Activation in the Development of Immune Tolerance in Women with Recurrent Pregnancy Loss

  2020cites this paper
• HLA antibody repertoire in infants suggests selectivity in transplacental crossing

  2020cites this paper